Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis

Infliximab is a chimeric, monoclonal anti-tumour necrosis factor-alpha antibody. It has been previously demonstrated to be an effective treatment for patients with Crohn’s disease who do not achieve the desired response with conventional treatments. Although the etiology of ulcerative colitis (UC) d...

全面介紹

書目詳細資料

Principais autores:	Remo Panaccione, Richard N Fedorak, Guy Aumais, Edmond-Jean Bernard, Charles N Bernstein, Alain Bitton, Ken Croitoru, Levinus A Dieleman, Robert Enns, Brian G Feagan, Denis Franchimont, Gordon R Greenberg, Anne-Marie Griffiths, John K Marshall, Pierre Pare, Sunil Patel, Robert Penner, Craig Render, Ernest Seidman, A Hillary Steinhart
格式:	Artigo
語言:	Inglês
出版:	Wiley 2008-01-01
叢編:	Canadian Journal of Gastroenterology
在線閱讀:	http://dx.doi.org/10.1155/2008/493405
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!